CD4 and malignant colon neoplasm: Furumoto et al. injected CT26 colon cancer cells transfected with MIP-3α and observed that the numbers of TIDCs and CD4+ and CD8+ T cells in the tumors that developed were significantly higher, as was the in vitro cytotoxicity of CTLs (31).